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Abstract
Purpose Adverse effects of maternal vitamin B12 deficiency have been linked to major clinical outcomes, including increased
body mass index and gestational diabetes, however, less is known about vitamin B12 nutrition in non-pregnant women. Hence,
the aim of the present study was to explore the relationships betweenmetabolic traits and vitamin B12 status in a cohort of healthy
Indonesian women and to investigate whether these relationships were modified by dietary intake using a genetic approach.
Methods A total of 117 Minangkabau women (aged 25–60 years), from the city of Padang, West Sumatra underwent anthro-
pometric, biochemical, dietary intake analysis and genetic tests. Genetic risk scores (GRS) based on nine vitamin B12 associated
single nucleotide polymorphisms (SNPs) (B12-GRS) and nine metabolic SNPs (metabolic-GRS) were constructed.
Results The B12-GRS and metabolic-GRS had no effect on vitamin B12 (P > 0.160) and metabolic traits (P > 0.085). However,
an interaction was observed between the B12-GRS and dietary fibre intake (g) on glycated haemoglobin (HbA1C) levels (P
interaction = 0.042), where among those who consumed a low fibre diet (4.90 ± 1.00 g/day), individuals carrying ≥9 risk alleles for
vitamin B12 deficiency had significantly higher HbA1C levels (P = 0.025) compared to those carrying ≤8 risk alleles.
Conclusion Our study showed a significant impact of the B12-GRS on HbA1C concentrations through the influence of a dietary
factor, however, our study failed to provide evidence for an impact of metabolic-GRS on lowering B12 concentrations. Further
replication studies utilizing larger sample sizes are needed to confirm our findings.
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SNPs single nucleotide polymorphisms
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TCN1 Transcobalamin 1
FUT6 Fucosyltransferase 6
MUT Methylmalonyl-CoA mutase
CAP10 Calpain 10
KCNJ11 Potassium voltage-gated channel subfamily J
member 11
TCF7L2 Transcription factor 7-like 2
FTO Fat mass and obesity-associated
MC4R Melanocortin 4 Receptor
BMI body mass index
SD indicates standard deviations
WC waist circumference
Introduction
Vitamin B12 adequacy plays a critical role in a multitude of
physiological processes, including DNA synthesis, haemato-
logical development and neurological function [1, 2].
Moreover, vitamin B12 is now known to play a much more
profound and wide-ranging role in maternal health as well as
foetal development [3, 4]. Low maternal plasma concentra-
tions of vitamin B12 have shown negative correlations with
body mass index (BMI) levels in healthy women [5] and have
been associated with pregnancy complications such as gesta-
tional diabetes mellitus [3], recurrent pregnancy loss [6],
higher BMI [7] and neural tube defects [8]. Notably, the harm-
ful effects of maternal malnutrition are not just confined to
pregnancy complications and birth defects. Findings from
the Pune Maternal Nutrition Study (PMNS) in India have
shown that low maternal vitamin B12 increases the risk of
insulin resistance and relative adiposity in 6- to 7-y-old chil-
dren, with the highest levels of insulin resistance occurring
when mothers had a combination of a high folate and low
vitamin B12 status [7].
Suboptimal vitamin B12 status has been shown to be prev-
alent in many countries [9]. Published data on vitamin B12
status of any life-stage group in Indonesian women is lacking
with the exception of an earlier report in 2017 showing that the
prevalence of a vitamin B12 deficient diet was 34.5% in 606
Indonesian pregnant women (14–49 years) [10]. The
Minangkabau culture in Indonesia is of particular interest, as
it is the world’s largest matrilineal system of kinship, where
women hold greater power in both family and society [11].
Food supply is centred around women and compelling evi-
dence suggests that adequate nutrition protects against meta-
bolic disorders related to obesity [12], as a result understand-
ing the dietary patterns of women in relation to their genetic
susceptibility is of great importance.
Although vitamin B12 deficiency is associated with a wide
range of chronic diseases and conditions, including obesity,
and with increasing severity of metabolic dysfunction, such as
insulin dysregulation [13–16], the relationship between low
vitamin B12 status and obesity related traits has remained
inconsistent [17]. It is possible that certain genotypes might
jointly contribute to obesity and vitamin B12 deficiency [17]
and the implementation of a genetic approach to establish the
relationship between vitamin B12 and obesity could be a more
desirable option over observational studies, as results are less
prone to confounding factors. While genetic studies have im-
plicated several gene loci in the predisposition to vitamin B12
deficiency, no study has yet been carried out in the Indonesian
population [18]. Hence, for the first time we used a genetic
approach to explore the relationship between metabolic traits
and vitamin B12 status and investigated whether these rela-
tionships were modified by lifestyle factors in a cohort of
Minangkabau women in Padang. Identifying the impact of
vitamin B12 status on metabolic traits will help us to reduce
the burden of metabolic diseases through implementation of
policies for screening of vitamin B12 deficiency.
Methodology
The Minangkabau Indonesia Study on Nutrition and Genetics
(MINANG) study is a cross-sectional pilot study that was
conducted in the city of Padang, West Sumatra, Indonesia,
between December 2017 to January 2018. This study was
conducted as part of the ongoing GeNuIne (Gene-Nutrient
Interactions) Collaboration, the main objective of which is
to investigate the effect of gene-nutrient interactions
(nutrigenetics) on metabolic disease outcomes using popula-
tion based studies from various ethnic groups [19]. The study
was conducted in accordance with the principles of the
Declaration of Helsinki and was approved by the Ethical
Review Committee of the Medical Faculty, Andalas
Univesity (No.311/KEP/FK/2017). All participants provided
written informed consent before participating. Participants
were allowed to leave the study at will and opt out from any
of the procedures. One hundred and thirty-three women were
recruited from community health centers in two sub districts
in Padang City to represent both urban (50% Padang Timur)
and rural (50%Kuranji) areas of Padang population. Inclusion
criteria were healthy women (between 25 and 60 years old)
with Minangkabau ethnicity. Among the 133 eligible adults,
10 adults were excluded from the study. Exclusion criteria
included the following: having a previous history of type 2
diabetes, cardiovascular disease or hypertension (n = 6), hav-
ing a BMI of more than 40 kg/m2 or being classified as mor-
bidly obese by a physician (n = 0), being blood related to other
participants in the study (n = 0), having any communicable
disease (n = 4), being pregnant or lactating (n = 0) and taking
dietary or vitamin supplements (n = 0). Among the 123 re-
maining adults, 5 volunteers did not undergo blood sample
collection and were excluded from the study and one partici-
pant did not undertake the validated semi-quantitative food
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frequency questionnaire (FFQ) [20]. The final sample
consisted of 117 women who completed a FFQ and
underwent blood sample collection for biochemical and ge-
netic analysis (Fig. 1).
Anthropometric measures
Body weight was measured to the nearest 100 g using an
electronic scale (Seca 803, Seca GmbH. Co. kg, Hamburg,
Germany) and height was measured to the nearest mm using
a s tadiometer (OneMed Medicom sta ture meter,
YF.05.05.V.A.1022, Indonesia). The BMI was estimated as
weight (kg) divided by the height (m) squared. BMI was clas-
sified according to the Asia-Pacific classification for BMI/age
according to sex [21]. The waist (cm) circumference was mea-
sured in a standing position with the feet positioned close
together. The waist circumference (WC) was measured using
a metal tape (Medline-OneMed Medicom, Jakarta, Indonesia)
midway between the lower border of the rib cage and the iliac
crest, at the end of gentle expiration. Body fat percentage was
measured using the Tanita MC780 multi frequency segmental
body composition analyser.
Biochemical measures
For the determination of biochemical parameters, blood sam-
ples (5 ml) were collected by a trained phlebotomist in the
morning, after a 12 h fast. The blood samples were used to
measure vitamin B12, glucose, insulin and glycated hemoglo-
bin (HbA1c). All biochemical samples were assayed using the
xMark Microplate Spectrophotometer (Bio-Rad Laboratories
Inc., Hercules, California, USA). Serum concentrations of vi-
tamin B12, glucose, insulin and HbA1c were assessed using
enzyme-linked immunosorbent assay (ELISA) kits from
Bioassay Technology Laboratory (Shanghai, China).
Assessment of dietary intake and physical activity
Data collection was completed by a qualified nutritionist in
the home or in an integrated health service post. Dietary in-
takes were assessed using a previously validated and pub-
lished semi-quantitative food frequency questionnaire (SQ-
FFQ) containing 223 food items [20]. In brief, participants
were asked to estimate the usual frequency (number of times
per day, week or month) and the portion sizes of various food
items. Portion size photographs of all relevant foods (includ-
ing some prepared dishes) were used by participants while
completing the SQ-FFQ, to aid the estimation of portion size
intake [22]. All information provided by the participants was
double-checked for accuracy. The recorded data was analyzed
with the Indonesian Food Database and Nutrisurvey
(EBISpro, Germany) to estimate energy as well as macro-
and micronutrient consumption. Wherever appropriate, nutri-
ent intake values were adjusted to energy by the nutrient
(energy-adjusted) residual method [23].
“The Global Physical Activity Questionnaire” (GPAQ),
developed by the World Health Organization (WHO) was
used to measure physical activity [24]. Total time in
moderate-to-vigorous physical activity was calculated ac-
cording to the WHO STEPwise method and was expressed
as metabolic equivalent minutes per day (METmins/day).
Furthermore, participants were classified as “active” if they
accumulated ≥600 METmins/week or “inactive” if they did
<600 METmins/week. Sedentary behaviour (SB, mins/day)
was determined from the last question of the GPAQ, based
on how long the participants spent sitting while working, in
a vehicle, watching television, or lying down, except
sleeping [24].
SNP selection and genotyping
We s e l e c t e d n i n e v i t am i n B12 - r e l a t e d SNP s
(Methylenetetrahydrofolate reductase [MTHFR]- rs1801133,
Screened in 
Padang city
(n= 133) Lost to study (n= 10)
• Having previous history of type 2 diabetes, 
cardiovascular disease or hypertension (n=6)
• Having any communicable disease (n=4)
Consented to the 
study
(n= 123)
Withdrew from study (n= 6)
• Not willing to have blood collection (n=5)
• Did not complete the Food Frequency Questionnaire 
(n=1)
Completed the 
study
(n= 117)
Fig. 1 Flow chart of the subject
recruitment process
J Diabetes Metab Disord (2019) 18:389–399 391
Carbamoyl-phosphate synthase 1 [CPS1]- rs1047891,
Cubulin [CUBN]- rs1801222, CD320 molecule [CD320]-
rs2336573, Transcobalamin 2 [TCN2]- rs1131603,
Fucosyltransferase 2 [FUT2]- rs602662, Transcobalamin 1
[TCN1]- rs34324219, Fucosyltransferase 6 [FUT6]-
rs778805 and Methylmalonyl-CoA mutase [MUT]-
rs1141321) based on the recent review article by
Surendran et al. [18].
The nine metabolic disease-related SNPs were selected for
our analysis based on previously published candidate gene
association and genome-wide association (GWA) studies for
metabolic disease-related traits [25–33]: Fat mass and obesity-
associated [FTO]- rs9939609 and rs8050136, Melanocortin 4
Receptor [MC4R]- rs17782313 and rs2229616, Transcription
factor 7-like 2 [TCF7L2]- rs12255372 and rs7903146,
Potassium voltage-gated channel subfamily J member 11
[KCNJ11]- rs5219, Calpain 10 [CAPN10]- rs3792267 and
rs5030952).
Genomic DNA was isolated from peripheral blood leu-
kocytes using the PureLink Genomic DNA Mini Kit
(Invitrogen, Carlsbad, USA) with spin column methods.
The DNA concentrat ion was determined using a
NanoDrop spectrophotometer. Genotyping was performed
at LGC Genomics (http://www.lgcgroup.com/services/
genotyping), which employs the competitive allele-
specific PCR-KASP® assay.
Statistical analysis
The SPSS statistical package (version 22; SPSS Inc., Chicago,
IL, USA) was used for the statistical analysis. Results from the
descriptive analyses are presented as means and standard de-
viations (SD) for continuous variables and as percentages for
categorical variables. Generalized obesity was defined accord-
ing to the Asia-Pacific classification of BMI for Asians as
non-obese (BMI < 25 kg/m2) and obese (BMI ≥ 25 kg/m2)
[21]. We performed an independent t-test to compare the
means of the quantitative variables between non-obese indi-
viduals vs obese individuals. Comparison of the proportion of
individuals engaging in different types of physical activity
levels (vigorously active, moderately active and sedentary)
between non-obese individuals vs obese individuals was ana-
lyzed by the Chi Square test. The normality of variable distri-
bution was verified by the Shapiro-Wilk test; WC, body fat
percentage, glucose, insulin, HbAC1 and vitamin B12 levels
were not normally distributed in our study population; there-
fore, the data were natural log-transformed prior to analysis.
Allele frequencies were estimated by gene counting. The
Chi-square test was used to compare the proportions of geno-
types or alleles. Fifteen of the SNPs were in Hardy Weinberg
Equilibrium (HWE) (P > 0.05) (Table 1). HWE was not cal-
culated for the SNPs TCN2 rs1131603 and TCN1 rs34324219
as no minor alleles were present. The SNP FUT2 rs602662
Table 1 Genotype distribution of vitamin B12 related SNPs and metabolic disease-related SNPs
Gene rs number Major
allele
Minor
allele
CommonHomozygotes (%) Heterozygotes
(%)
Rare Homozygotes (%) Minor allele frequency HWE P
value
MTHFR rs1801133 C T 92 (79.30) 24 (20.70) 0 (0.00) 0.10 0.214
CPS1 rs1047891 C A 48 (41.00) 56 (47.90) 13 (11.10) 0.35 0.579
CUBN rs1801222 C T 84 (74.30) 27 (23.90) 2 (1.80) 0.14 0.920
CD320 rs2336573 C T 86 (74.10) 29 (25.00) 1 (0.90) 0.13 0.390
TCN2 rs1131603 T C 117 (100) 0 (0.00) 0 (0.00) 0 N/A
FUT2 rs602662 G A 111 (94.90) 4 (3.40) 2 (1.70) 0.03 0.000
TCN1 rs34324219 C A 117 (100) 0 (0.00) 0 (0.00) 0 N/A
FUT6 rs778805 T C 33 (28.20) 61 (52.10) 23 (19.70) 0.46 0.586
MUT rs1141321 G A 67 (59.30) 40 (35.40) 6 (5.30) 0.23 0.993
CAP10 rs3792267 G A 108 (91.50) 9 (7.60) 1 (0.80) 0.05 0.123
CAP10 rs5030952 C T 77 (66.40) 31 (26.70) 8 (6.90) 0.20 0.063
KCNJ11 rs5219 C T 55 (47.00) 47 (40.20) 15 (12.80) 0.33 0.329
TCF7L2 rs12255372 G T 97 (82.90) 20 (17.10) 0 (0.00) 0.09 0.312
TCF7L2 rs7903146 C T 95 (81.90) 21 (18.10) 0 (0.00) 0.09 0.284
FTO rs9939609 T A 70 (60.30) 39 (33.60) 7 (6.00) 0.23 0.618
MC4R rs17782313 T C 89 (76.10) 26 (22.20) 2 (1.70) 0.13 0.929
FTO rs8050136 C A 69 (60.00) 39 (33.90) 7 (6.10) 0.23 0.638
MC4R rs2229616 G A 116 (99.10) 1 (0.90) 0 (0.00) 0.00 0.963
MAF minor allele frequency, HWE Hardy Weinberg Equilibrium, X2 Chi-Squared value
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deviated from HWE; however, this SNP was not excluded
from analysis. The KASP™ genotyping technology used in
this study, has been independently assessed to be over 99.8%
accurate [34]. Validation of the KASP™ genotyping was con-
ducted at LGC genomics and the quality of the genotyping
results were independently assessed and confirmed by the
project manager. This ruled out genotyping artefacts as possi-
ble reasons for deviation from HWE. Hence, it is possible
that the SNP FUT2 rs602662 could have deviated from
HWE due to population or racial grouping substructure
(Sub-grouping), non-random mating, linkage disequilibri-
um (incomplete mixing of different ancestral population) or
chance findings [35].
A schematic representation of the study design is presented
in Fig. 2. The unweighted, risk-allele GRS method was calcu-
lated for each participant as the sum of risk allele counts across
each SNP which predicted vitamin B12 status. The B12-GRS
was generated from the vitamin B12-related SNPs in the
MTHFR, CPS1, CUBN, CD320, TCN2, FUT2, TCN1,
FUT6, MUT genes. Furthermore, another unweighted GRS
was created using allele markers previously reported to be
associated with metabolic disease traits. The Metabolic-GRS
was generated from the SNPs in the CAP10, KCNJ11,
TCF7L2, FTO and MC4R genes. A value of 0, 1 or 2 was
assigned to each SNP, which denotes the number of risk al-
leles on that SNP. These values were then calculated by
adding the number of risk alleles across each SNP. The
average number of risk alleles per person for the B12-GRS
was 8.18 (SD = 1.36), which ranged from 5 to 12. The sample
was stratified, by the median, into a “low genetic risk group,”
for those with a GRS ≤ 8 risk alleles (n = 73), and into a “high
genetic risk group,” for those with a GRS ≥ 9 risk alleles (n =
44). For the metabolic-GRS, the average number of risk al-
leles per person was 4.66 (SD = 1.76), which ranged from 2 to
9. The sample was stratified, by the median, into a “low ge-
netic risk group,” for those with a GRS ≤ 4 risk alleles (n =
61), and into a “high genetic risk group,” for those with a
GRS ≥ 5 risk alleles (n = 56). Linear regression was used to
examine the association of the two GRS scores with the bio-
chemical and anthropometric outcomes (vitamin B12, glucose,
insulin, HbA1c, BMI, WC and body fat percentage). The in-
teraction between the two GRS scores and dietary factors on
biochemical and anthropometric outcomes was determined by
including interaction term (GRS*lifestyle factor) in the regres-
sion model. Models were adjusted for age, BMI, and total
energy intake, wherever appropriate. Correction for multiple
testing was applied using Bonferroni correction [2 GRS * 7
biochemical and anthropometric measurements (vitamin B12,
glucose, insulin, HbA1c, BMI, WC, body fat percentage) * 5
lifestyle factors (dietary carbohydrate (energy %), dietary pro-
tein (energy %), dietary fat (energy %), dietary fibre (g) and
physical activity levels) = 70 tests; 0.05/70 = 0.000714;
P < 0.000714]. All data are expressed as mean ± SD. Given
that there are no studies on GRS in relation to B12 status and
Metabolic- GRS generated from the SNPs (CAP10, KCNJ11, TCF7L2, FTO 
and MC4R) that have been shown to be associated with metabolic disease 
outcomes 
Metabolic disease-related 
traits
Serum vitamin B12 
concentration               
Lifestyle 
factors
B12-GRS generated from SNPs (MTHFR, CPS1, CUBN, CD320, TCN2, FUT2, 
TCN1, FUT6, MUT) that have been shown to be associated with vitamin B12 
concentrations 
Lifestyle 
factors
Lifestyle 
factors
Lifestyle 
factors
Fig. 2 Diagram representing the study design. Four possible associations,
and four possible interactions were examined. One-sided arrows with
unbroken lines represent genetic associations and one-sided arrows with
broken lines represent interactions between a GRS and a lifestyle factor
on serum vitamin B12/ metabolic traits (such as glucose, insulin, HbA1c,
BMI, WC and body fat percentage). The association of the metabolic-
GRSwith vitamin B12 concentrations andmetabolic disease-related traits
and the association of B12 –GRS with vitamin B12 concentrations and
metabolic disease related traits were tested. Lastly, the impact of lifestyle
factors (macronutrient intakes and physical activity levels) on these
genetic associations was investigated
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metabolic outcomes and no previously reported effect sizes
for the South-East Asians, we were unable to perform a power
calculation.
Results
Characteristics of the participants
In this study, 117 women (mean age, 40.30 ± 10.10 years;
BMI, 25.10 ± 4.20 kg/m2) were included. Table 2 illustrates
the main characteristics of the study participants.
Association between B12-GRS and metabolic-GRS
with biochemical and anthropometric measurements
After correction for multiple testing, none of the associations
of the B12-GRS with vitamin B12 and metabolic traits
(P > 0.160) were statistically significant (Supplementary
Table 1). Furthermore, no associations between the
metabolic-GRS and vitamin B12 or metabolic traits
(P > 0.085) were observed (Supplementary Table 2).
Interaction between the B12-GRS and dietary factors
on biochemical and anthropometric measurements
We observed an interaction between the B12-GRS and dietary
fibre intake (g) on log transformed HbA1C (Pinteraction =
0.042) (Fig. 3 and Supplementary Table 3). Individuals who
carried 9 or more risk alleles for vitamin B12 deficiency had
8.10% higher HbAC1 concentrations (ng/ml) in the lowest
tertile of fibre intake (g) (Mean ± S.D.: 4.90 ± 1.00 g) com-
pared to those with 8 or less risk alleles for vitamin B12
deficiency.
Interactions were also seen between the B12-GRS and pro-
tein (energy %) on log transformed body fat percentage (P =
0.034). However, further stratification of participants based on
their consumption of low-, medium- and high-dietary protein
(energy %) did not show a statistically significant association
between the GRS and the outcomes in any of the tertiles.
Table 2 Anthropometric and biochemical characteristics of women participants
All women Non-obese* Obese** P value***
(N = 117) (N = 32) (N = 85)
Age (yrs) 40.40 ± 10.20 35.70 ± 11.30 42.10 ± 9.20 0.006
Height (cm) 152.90 ± 5.20 154.90 ± 4.70 152.20 ± 5.20 0.012
BMI (kg/m2) 25.10 ± 4.20 20.10 ± 2.10 27.00 ± 3.10 <0.001
WC (cm) 83.10 ± 12.50 72.80 ± 13.30 87.00 ± 9.70 <0.001
Body fat (%) 35.70 ± 7.00 27.00 ± 5.20 39.00 ± 4.30 <0.001
Fasting serum Glucose (mg/dl) 92.20 ± 20.20 85.70 ± 9.00 94.70 ± 22.70 0.033
Fasting serum Insulin (mIU/L) 32959 ± 26327 30372 ± 26179 33933 ± 26470 0.517
HbA1C (ng/ml) 662 ± 624 638 ± 606 672 ± 633 0.794
Fasting vitamin B12 (pg/mL) 591 ± 579 426 ± 137 433 ± 193 0.795
Physical Activity Levels Sedentary (39.30%) Sedentary (46.90%) Sedentary (36.50%) 0.490a
Moderate (49.60%) Moderate (40.60%) Moderate (52.90%)
Vigorous (11.10%) Vigorous (12.50%) Vigorous (10.60%)
Total energy (kcal/d) 1774 ± 609 1849 ± 585 1746 ± 619 0.416
Protein (g) 76.90 ± 36.50 80.50 ± 29.00 75.50 ± 39.00 0.514
Fat (g) 59.00 ± 33.10 67.30 ± 27.70 55.80 ± 34.60 0.096
Carbohydrate (g) 233 ± 71 230 ± 70 235 ± 72 0.714
Dietary fibre (g) 8.80 ± 4.50 9.70 ± 4.80 8.50 ± 4.40 0.222
Saturated Fat (g) 20.90 ± 11.10 23.70 ± 11.10 19.80 ± 10.90 0.085
MUFA (g) 8.20 ± 4.50 9.80 ± 5.20 7.50 ± 4.20 0.015
PUFA (g) 6.30 ± 3.50 6.80 ± 3.20 6.10 ± 3.60 0.332
Data shown are represented as means ± SD
P values were calculated by using the Independent t test
Abbreviations: BMI Body mass index; WC Waist circumference; MUFA Monounsaturated fatty acids; PUFA Polyunsaturated fatty acids
*Non-Obese individuals refers to the percentage of individuals with a BMI of under 23 according to the Asia-Pacific classification of BMI
**Obesity cases refers to the percentage of individuals with a BMI of equal to or over 23 according to the Asia-Pacific classification of BMI
***P values for the differences in the means/ proportions between non-obese and obese individuals
a P values were calculated by using the Chi Squared test
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Interaction between the metabolic-GRS and dietary
factors on biochemical and anthropometric
measurements
An interaction was found between the metabolic-GRS and
protein (energy %) on log transformed WC (P = 0.032)
(Supplementary Table 3 and Fig. 4). Individuals who carried
5 or more risk alleles for metabolic disease had 2.15% lower
WC measurements (cm) in the lowest tertile of protein energy
intake (%) (Mean ± S.D.: 1.91 ± 0.06%) compared to those
with 4 or less risk alleles (P = 0.027) (Fig. 4).
Interaction between the B12-GRS and physical
activity on biochemical and anthropometric
measurements
No statistically significant interactions were observed between
the two GRSs (vitamin B12 and metabolic traits) and physical
activity on biochemical and anthropometric measurements
(P > 0.056) (Supplementary Table 3).
After correction for multiple testing (Bonferroni corrected
<0.000714), none of these GRS-lifestyle interactions were
considered statistically significant.
Discussion
To our knowledge, this is the first study to use a nutrigenetic
approach to explore the relationship between vitamin B2 sta-
tus and metabolic traits in Indonesian women. Our study dem-
onstrated the impact of genetically instrumented B12 concen-
trations on HbA1C levels, a marker of glycaemic control [36],
through the influence of dietary fibre intake. Given that pre-
vious studies have shown that the consumption of dietary fibre
is inadequate in Indonesian adults [37–39], our findings, if
replicated in future studies, may have significant public health
implications in terms of encouraging a consumer education
campaign targeted around increasing fibre intake, in order to
reduce HbA1C levels, which may be associated with im-
proved glycaemic control.
In the present study, we constructed a GRS consisting of
nine vitamin B12 decreasing SNPs in genes involved in vita-
min B12 metabolism [18]. Our study showed that individuals
carrying less than 8 risk alleles for vitamin B12 deficiency had
higher vitamin B12 concentrations, compared to those carry-
ing more than 9 risk alleles. However, there was no statistical-
ly significant difference between individuals carrying 8 or less
risk alleles vs 9 or more risk alleles for the B12-GRS, which
could be attributed to the small sample size. Furthermore, we
were unable to identify any association between the B12-GRS
and metabolic disease traits in our study, implying that linear
decreases in vitamin B12 may not have a role in the develop-
ment of metabolic disease traits. Our finding goes in line with
a Mendelian Randomization study investigating the effect of
genetically instrumented vitamin B12 concentrations on BMI,
where there was no evidence to suggest the causal role of
decreased serum vitamin B12 levels in obesity [40].
Interestingly, in our study, we found a significant interac-
tion between the B12-GRS and dietary fibre intake (g) on log
HbA1C levels, where, among those who consumed a low
fibre diet (Mean ± S.D.: 13.60 ± 4.30), individuals carrying
more than 9 risk alleles had significantly higher HbAC1 levels
compared to those carrying 8 or less risk alleles. The average
fibre intake in Indonesia is 10.5 g/day [41], which is lower
compared to the mean fibre intake in the UK (~18 g/day) and
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USA (~16 g/day) [28]. In comparison to the mean fibre intake
in Indonesia, the results in our study reported a lower mean
fibre intake (8.80 ± 4.50 g). It is important that dietary intakes
of fibre are increased in this population, as it may help main-
tain lower levels of HbAC1 levels in individuals carrying
more than 9 risk alleles of the B12-GRS. Even though our
study is the first to report this gene-diet interaction, a meta-
analysis conducted from 15 randomized studies have shown
that high fibre intake can reduce HbAC1 levels in type 2
diabetic subjects [42]. High fibre intake is generally recom-
mended to reduce the risk of gestational diabetes (GDM) in
pregnant women [43]. It has been shown that each 10 g/day
increment in total fibre intake, corresponds to a 26% reduced
risk of GDM [43]. It is possible that high dietary fibre may
increase satiety and consequently reduce total energy intake
[44, 45]. Increased dietary fibre intake may also affect glucose
homeostasis, by delaying gastric emptying, resulting in a
slower absorption of glucose into the blood stream [43].
Additionally, low vitamin B12 status prevents erythropoiesis
and prolongs the lifespan of erythrocytes, resulting in in-
creased HbA1c levels [46]. This is the first study to provide
evidence for an interaction between B12-GRS and HbA1c,
hence, we do not have any previous studies to compare our
findings with.
Accurately determining obesity has become an exceeding-
ly important step in preventing the onset of metabolic syn-
drome or cardiometabolic diseases, which are brought about
through excess adiposity. The underestimation of obesity, par-
ticularly in young women who appear to have a healthy BMI
measure, could falsely lead to incorrect conclusions about
body composition and future risk of diseases associated with
increased adiposity, such as breast cancer [47]. The ability to
measure body fat percentage is currently the preferred method
of determining body composition over BMI, as it distin-
guishes between fat and lean body mass [48]. To date, little
is known about the average body fat percentage in healthy
Indonesian women. Although, a recent study conducted in
308 Indonesian women of Javanese ethnicity living in
Yogyakarta Special Region Province (aged between 18 and
65), reported lower body fat percentage values (33.30 ±
7.70%) compared to our present study (35.70 ± 7.00%) [49].
Within our study, an interaction between the B12-GRS and
protein intake (energy %) on log transformed body fat per-
centage was observed. The exact mechanism of how dietary
protein results in a more favourable body composition profile
in individuals genetically predisposed to vitamin B12 defi-
ciency is not known. A previous study conducted in 1,834
participants in Canada reported that high protein diets could
reduce overall body fat percentage, even in the absence of
energy restriction [50]. Further to this, it has been
hypothesised that high protein diets increase the release of
the anorectic gut hormone peptide YY (PYY), thus enhancing
greater inter-meal satiety and reducing weight gain [51]. This
suggestion for a novel interaction of protein (energy intake) in
relation to body fat distribution in individuals genetically
predisposed to vitamin B12 deficiency warrants further
replication.
In a review analysing the nutrient intakes of pregnant wom-
en in Indonesia, it was reported that pregnant Indonesian
women generally have protein intakes below the estimated
average requirements [52]. The association between low pro-
tein intake and obesity outcomes has attracted interest
amongst health care professionals. Observational studies in
the USA have reported that body weight and WC were re-
duced when protein was consumed above the recommended
daily allowance [0.8 g/kg body weight (BW)] [53]. It has been
noted in animal models, that pregnant rats consuming a low
protein diet were more prone to GDM and to having offspring
with a low birthweight [54, 55]. In our study, we found a
significant interaction between the metabolic-GRS and pro-
tein energy (%) on log WC, where individuals consuming a
low protein diet, despite carrying 5 or more risk alleles, had a
lower waist to hip ratio compared to individuals carrying 4 or
less risk alleles. There are no previous reports of the risk var-
iants used in our GRS, but Goni et al. [36] found that total
protein intake interacted with a GRS of 16 obesity/lipid me-
tabolism polymorphisms to modify the effect on body fat
mass in 711 individuals of Caucasian ancestry. In our study,
we only observed interaction of the metabolic-GRS with WC
but not BMI, which suggests that effects of the GRS are likely
to be on central obesity as opposed to common obesity in
Indonesian women.
Significant interactions between genetic variants and phys-
ical activity on obesity traits have been reported in several
studies from Europe and Asia [56, 57]. However, this is the
first study to investigate interactions between the two GRSs
and physical activity on metabolic traits and B12 concentra-
tions in Indonesian women. In our study, as much as 39% of
the women had low physical activity levels. These findings
were much higher than the findings reported from another
cross sectional study conducted across five major cities in
Indonesia, who reported that 20% of women had a low phys-
ical activity status [58]. Although the majority of women in
our study were physically inactive, no significant interactions
were found between the GRSs and physical activity on meta-
bolic traits/B12 status, which could be due to the small sample
size of our study.
Major strengths of our study are that this is the first study of
its kind to evaluate vitamin B12 status among Indonesian
women. Furthermore, this study used a comprehensive, vali-
dated, interviewer administered food frequency questionnaire
[20] to measure the long-term macronutrient intake of the
population. Nevertheless, several limitations of this study
need to be considered. One of the main limitations of the study
is the small sample size (N = 117); however, we were still able
to identify significant associations and gene-lifestyle
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interactions. Given that the study used a SQ-FFQ, self-
reported data might have biased the dietary intake informa-
tion. The study had included data on total energy and macro-
nutrient intake but no data on specific types of foods or
micronutrients were included. This limited the analysis of
testing for interaction of specific food components with
GRS on various outcome measures. Circulating concentra-
tions of other vitamin B12 biomarkers, such as Holo-
transcobalamin (holoTC) or Methylmalonic Acid (MMA)
were not measured. Furthermore, all the women included in
our analysis were of Minangkabau descent, and thus it is un-
known whether our results can be generalized to other com-
munities in Indonesia.
In conclusion, our study showed a significant effect of the
B12-GRS on HbA1C concentrations, through the influence of
a low dietary fibre intake. Additionally, our study failed to
provide evidence for an impact of metabolic-GRS on lowering
B12 concentrations. After correction for multiple testing, none
of the interactions were statistically significant; hence, further
replication studies utilizing larger sample sizes are needed to
confirm our findings, before public health recommendations
and personalized nutrition advice can be developed for
Minangkabau Indonesian women.
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